Clinical Trial Update: Glutathione and Its Precursors in HIV-Infected Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated glutathione and its precursors in HIV-infected patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Glutathione (glutathione)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: HIV Infection | Phase 2 | Status: COMPLETED